Free Trial

LeMaitre Vascular (LMAT) Competitors

LeMaitre Vascular logo
$82.06 +1.29 (+1.60%)
As of 02:16 PM Eastern
This is a fair market value price provided by Polygon.io. Learn more.

LMAT vs. GKOS, BLCO, SLNO, IRTC, INSP, TMDX, NVST, PRCT, WRBY, and LIVN

Should you be buying LeMaitre Vascular stock or one of its competitors? The main competitors of LeMaitre Vascular include Glaukos (GKOS), Bausch + Lomb (BLCO), Soleno Therapeutics (SLNO), iRhythm Technologies (IRTC), Inspire Medical Systems (INSP), TransMedics Group (TMDX), Envista (NVST), PROCEPT BioRobotics (PRCT), Warby Parker (WRBY), and LivaNova (LIVN). These companies are all part of the "medical equipment" industry.

LeMaitre Vascular vs. Its Competitors

LeMaitre Vascular (NASDAQ:LMAT) and Glaukos (NYSE:GKOS) are both medical companies, but which is the better investment? We will contrast the two companies based on the strength of their earnings, media sentiment, risk, institutional ownership, dividends, profitability, valuation and analyst recommendations.

84.6% of LeMaitre Vascular shares are held by institutional investors. Comparatively, 99.0% of Glaukos shares are held by institutional investors. 9.5% of LeMaitre Vascular shares are held by insiders. Comparatively, 5.8% of Glaukos shares are held by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company is poised for long-term growth.

LeMaitre Vascular has a net margin of 19.96% compared to Glaukos' net margin of -31.40%. LeMaitre Vascular's return on equity of 13.53% beat Glaukos' return on equity.

Company Net Margins Return on Equity Return on Assets
LeMaitre Vascular19.96% 13.53% 9.78%
Glaukos -31.40%-10.66%-8.06%

LeMaitre Vascular currently has a consensus price target of $97.83, suggesting a potential upside of 19.59%. Glaukos has a consensus price target of $134.67, suggesting a potential upside of 42.76%. Given Glaukos' stronger consensus rating and higher possible upside, analysts plainly believe Glaukos is more favorable than LeMaitre Vascular.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
LeMaitre Vascular
0 Sell rating(s)
4 Hold rating(s)
2 Buy rating(s)
0 Strong Buy rating(s)
2.33
Glaukos
1 Sell rating(s)
1 Hold rating(s)
10 Buy rating(s)
0 Strong Buy rating(s)
2.75

In the previous week, LeMaitre Vascular had 2 more articles in the media than Glaukos. MarketBeat recorded 6 mentions for LeMaitre Vascular and 4 mentions for Glaukos. LeMaitre Vascular's average media sentiment score of 1.17 beat Glaukos' score of 1.05 indicating that LeMaitre Vascular is being referred to more favorably in the media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
LeMaitre Vascular
3 Very Positive mention(s)
1 Positive mention(s)
0 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive
Glaukos
2 Very Positive mention(s)
0 Positive mention(s)
2 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive

LeMaitre Vascular has a beta of 0.82, indicating that its stock price is 18% less volatile than the S&P 500. Comparatively, Glaukos has a beta of 0.82, indicating that its stock price is 18% less volatile than the S&P 500.

LeMaitre Vascular has higher earnings, but lower revenue than Glaukos. Glaukos is trading at a lower price-to-earnings ratio than LeMaitre Vascular, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
LeMaitre Vascular$219.86M8.41$44.04M$1.9841.32
Glaukos$383.48M14.06-$146.37M-$2.37-39.80

Summary

LeMaitre Vascular beats Glaukos on 9 of the 15 factors compared between the two stocks.

Get LeMaitre Vascular News Delivered to You Automatically

Sign up to receive the latest news and ratings for LMAT and its competitors with MarketBeat's FREE daily newsletter.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding LMAT and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

LMAT vs. The Competition

MetricLeMaitre VascularMED PRODUCTS IndustryMedical SectorNASDAQ Exchange
Market Cap$1.85B$10.41B$5.70B$9.52B
Dividend Yield0.97%2.00%4.60%3.99%
P/E Ratio41.3216.9628.0020.01
Price / Sales8.4126.79457.41102.39
Price / Cash34.4023.2136.5558.97
Price / Book5.453.628.595.87
Net Income$44.04M$234.77M$3.24B$258.50M
7 Day Performance2.55%5.38%3.71%1.95%
1 Month Performance-3.24%7.26%10.26%12.31%
1 Year Performance-5.14%-14.31%34.07%19.02%

LeMaitre Vascular Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
LMAT
LeMaitre Vascular
2.6543 of 5 stars
$82.06
+1.6%
$97.83
+19.2%
-10.6%$1.85B$219.86M41.42490Positive News
Analyst Forecast
GKOS
Glaukos
4.3773 of 5 stars
$96.97
-0.7%
$134.67
+38.9%
-23.0%$5.58B$383.48M-40.92780Positive News
Upcoming Earnings
BLCO
Bausch + Lomb
3.0175 of 5 stars
$13.92
+0.1%
$15.45
+11.0%
-13.1%$4.92B$4.79B28.9613,500Upcoming Earnings
SLNO
Soleno Therapeutics
3.7624 of 5 stars
$86.97
-0.3%
$108.70
+25.0%
+82.7%$4.39BN/A-18.8230Positive News
IRTC
iRhythm Technologies
1.0589 of 5 stars
$135.52
-0.5%
$137.30
+1.3%
+35.9%$4.35B$591.84M-43.162,000Upcoming Earnings
INSP
Inspire Medical Systems
4.9111 of 5 stars
$125.13
-1.3%
$210.27
+68.0%
-8.0%$3.74B$802.80M58.451,246Positive News
Analyst Forecast
TMDX
TransMedics Group
2.117 of 5 stars
$103.61
-5.7%
$129.88
+25.3%
-28.4%$3.72B$441.54M80.79210Positive News
Upcoming Earnings
NVST
Envista
3.3406 of 5 stars
$19.47
-0.2%
$20.23
+3.9%
+26.8%$3.31B$2.51B27.4812,300News Coverage
Upcoming Earnings
PRCT
PROCEPT BioRobotics
2.5008 of 5 stars
$57.05
-2.2%
$84.13
+47.5%
-13.1%$3.23B$224.50M0.00430News Coverage
WRBY
Warby Parker
2.75 of 5 stars
$24.35
+1.7%
$22.88
-6.0%
+48.4%$2.50B$771.32M0.003,780News Coverage
Insider Trade
LIVN
LivaNova
3.3281 of 5 stars
$42.35
+0.9%
$59.29
+40.0%
-19.5%$2.29B$1.25B-10.352,900Positive News

Related Companies and Tools


This page (NASDAQ:LMAT) was last updated on 7/25/2025 by MarketBeat.com Staff
From Our Partners